Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ACTRIMS 2023 | EBV & MS risk at ACTRIMS

Anibal Chertcoff, MD, PhD, The University of British Columbia, Vancouver, Canada, shares his highlights from the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2023. Dr Chertcoff was particularly interested in the presentations discussing the role of Epstein Barr virus (EBV) in the development of multiple sclerosis (MS) and the association of other viral infections with an increased risk of MS. This interview took place at the ACTRIMS Forum 2023 in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.